4-[4-(4-Fluorophenyl)methylphenyl]piperidine → 5-[4-(4-(4-(4-Fluorophenyl)methylphenyl)piperidin-1-yl)butyryl]-2,3,4,5-tetrahydro-1,5-benzoxazepine

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	4-[4-(4-Fluorophenyl)methylphenyl]piperidine	HCID 15462120	—
Edukt	5-(4-Chlorobutyryl)-2,3,4,5-tetrahydro-1,5-benzoxazepine	HCID 19694250	—
Produkt	5-[4-(4-(4-(4-Fluorophenyl)methylphenyl)piperidin-1-yl)butyryl]-2,3,4,5-tetrahydro-1,5-benzoxazepine	HCID 19694273	—

Reaktionsschritte

The compound (16) synthesized in Reference Example 16 and the compound (7) synthesized in Reference Example 7 were used to produce the above compound in the same way as Example 1.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US05723475
Quelldatensatz	uspto-grants-1998_03
ORD ID	ord-1255beb210e449d39ea430d3d1fca98e
Quellennotiz	uspto-grants-1998_03